Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03381846 · ClinicalTrials.gov registry record · NA
Treatment of Dermatofibrosarcoma Protuberans in Patients 10 Years and Younger
A NA study of Dermatofibrosarcoma Protuberans, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
- 1
- Study location
NCT03381846 is a NA study of Dermatofibrosarcoma Protuberans that has completed, run by Mayo Clinic. The registered enrollment target is 7 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03381846, a NA study of Dermatofibrosarcoma Protuberans, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this proposed study is to assess effectiveness of MOHS micrographic surgery as a form of treatment for dermatofibrosarcoma protuberans in patients who are 10 years of age or younger through review of the patients at Mayo Clinic treated from 1988-2017, and to explore the challenges that providers face which may prevent them performing this potentially superior treatment. This study will provide a comparison of outcomes and recurrence rates in pediatric patients treated by MOHS versus traditional excision.
Conditions Studied
Interventions
- PROCEDURE MOHS micrographic surgery
- PROCEDURE Wide local excision
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2018-07-01 |
| Est. Completion | 2020-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03381846
The ClinicalTrials.gov registry entry for NCT03381846 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Dermatofibrosarcoma Protuberans appearing as the primary indexed condition, and to 2 interventions - of which MOHS micrographic surgery is the first listed.
NCT03381846 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT03381846 about?
NCT03381846 is a clinical study titled "Treatment of Dermatofibrosarcoma Protuberans in Patients 10 Years and Younger". The purpose of this proposed study is to assess effectiveness of MOHS micrographic surgery as a form of treatment for dermatofibrosarcoma protuberans in patients who are 10 years of age or younger through review of the patients at Mayo Clinic treated from 1988-2017, and to explore the challenges tha...
What is the current status of trial NCT03381846?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2018-07-01. Estimated completion is 2020-06-30.
What conditions does trial NCT03381846 study?
This clinical trial studies the following conditions: Dermatofibrosarcoma Protuberans.
What interventions are being tested in trial NCT03381846?
The interventions under investigation include: MOHS micrographic surgery (PROCEDURE), Wide local excision (PROCEDURE).
Who is sponsoring clinical trial NCT03381846?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03381846 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.